CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Regulation FD disclosure
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- NT 10-Q Other NT 10-Q
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Unregistered share sale · Bylaws or fiscal year change
- 8-K Event Agreement ended · Unregistered share sale · Other events
- DEF 14C Other DEF 14C
- PRE 14C Other PRE 14C
- 8-K Event Code of ethics change
- 10-Q Report Quarterly Report
Page 34 of 46 · 904 filings